Theradiag (France) Buy Hold or Sell Recommendation
| ALTHE Stock | EUR 0.16 0.01 5.88% |
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding Theradiag SA is 'Strong Sell'. A buy or sell recommendation provided by Macroaxis is an automated analysis based on historical performance and your stated risk tolerance. It serves as guidance on whether to purchase or sell Theradiag SA within the specified time frame.
Check out Theradiag Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Theradiag and provide practical buy, sell, or hold advice based on investors' constraints. Theradiag SA. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
Theradiag |
Execute Theradiag Buy or Sell Advice
The Theradiag recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Theradiag SA. Macroaxis does not own or have any residual interests in Theradiag SA or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Theradiag's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Out of control | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Responds to the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Theradiag Trading Alerts and Improvement Suggestions
| Theradiag SA generated a negative expected return over the last 90 days | |
| Theradiag SA has high historical volatility and very poor performance | |
| Theradiag SA has some characteristics of a very speculative penny stock | |
| Theradiag SA has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| The company reported the revenue of 1.48 M. Net Loss for the year was (3.76 M) with loss before overhead, payroll, taxes, and interest of (1.4 M). | |
| Theradiag SA has accumulated about 938.86 K in cash with (3.88 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.11. | |
| Roughly 23.0% of the company shares are held by company insiders |
Theradiag Returns Distribution Density
The distribution of Theradiag's historical returns is an attempt to chart the uncertainty of Theradiag's future price movements. The chart of the probability distribution of Theradiag daily returns describes the distribution of returns around its average expected value. We use Theradiag SA price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Theradiag returns is essential to provide solid investment advice for Theradiag.
| Mean Return | -1.18 | Value At Risk | -12 | Potential Upside | 9.38 | Standard Deviation | 6.38 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Theradiag historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Theradiag Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Theradiag or Health Care Equipment & Supplies sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Theradiag's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Theradiag stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -1.02 | |
β | Beta against Dow Jones | 1.50 | |
σ | Overall volatility | 6.53 | |
Ir | Information ratio | -0.17 |
Theradiag Volatility Alert
Theradiag SA is displaying above-average volatility over the selected time horizon. Theradiag SA is a potential penny stock. Although Theradiag may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Theradiag SA. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Theradiag instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Theradiag Fundamentals Vs Peers
Comparing Theradiag's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Theradiag's direct or indirect competition across all of the common fundamentals between Theradiag and the related equities. This way, we can detect undervalued stocks with similar characteristics as Theradiag or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Theradiag's fundamental indicators could also be used in its relative valuation, which is a method of valuing Theradiag by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Theradiag to competition |
| Fundamentals | Theradiag | Peer Average |
| Return On Asset | -0.25 | -0.14 |
| Operating Margin | (8.41) % | (5.51) % |
| Current Valuation | 20.58 M | 16.62 B |
| Shares Outstanding | 28.8 M | 571.82 M |
| Shares Owned By Insiders | 22.50 % | 10.09 % |
| Shares Owned By Institutions | 7.88 % | 39.21 % |
| Price To Book | 10.04 X | 9.51 X |
| Price To Sales | 34.41 X | 11.42 X |
| Revenue | 1.48 M | 9.43 B |
| Gross Profit | (1.4 M) | 27.38 B |
| EBITDA | (4.48 M) | 3.9 B |
| Net Income | (3.76 M) | 570.98 M |
| Cash And Equivalents | 938.86 K | 2.7 B |
| Cash Per Share | 0.11 X | 5.01 X |
| Total Debt | 2.05 M | 5.32 B |
| Debt To Equity | 909.10 % | 48.70 % |
| Current Ratio | 1.63 X | 2.16 X |
| Book Value Per Share | (0.06) X | 1.93 K |
| Cash Flow From Operations | (3.88 M) | 971.22 M |
| Earnings Per Share | (0.19) X | 3.12 X |
| Target Price | 7.0 | |
| Number Of Employees | 28 | 18.84 K |
| Beta | 0.43 | -0.15 |
| Market Capitalization | 20.16 M | 19.03 B |
| Total Asset | 10.83 M | 29.47 B |
| Z Score | 5.4 | 8.72 |
| Net Asset | 10.83 M |
Theradiag Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Theradiag . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Theradiag Buy or Sell Advice
When is the right time to buy or sell Theradiag SA? Buying financial instruments such as Theradiag Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Theradiag in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Pharmaceutical Products Thematic Idea Now
Pharmaceutical Products
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Pharmaceutical Products theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Pharmaceutical Products Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Theradiag Stock Analysis
When running Theradiag's price analysis, check to measure Theradiag's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theradiag is operating at the current time. Most of Theradiag's value examination focuses on studying past and present price action to predict the probability of Theradiag's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theradiag's price. Additionally, you may evaluate how the addition of Theradiag to your portfolios can decrease your overall portfolio volatility.